{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T07:04:26Z","timestamp":1786863866968,"version":"build-2736575974"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017531","name":"Gandhi Institute of Technology and Management","doi-asserted-by":"publisher","award":["GRIG"],"award-info":[{"award-number":["GRIG"]}],"id":[{"id":"10.13039\/100017531","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DST-FIST","award":["SR\/FST\/LSI-568\/2013"],"award-info":[{"award-number":["SR\/FST\/LSI-568\/2013"]}]},{"name":"DST-ANRF","award":["CRG\/2023\/001951"],"award-info":[{"award-number":["CRG\/2023\/001951"]}]},{"DOI":"10.13039\/501100001411","name":"ICMR","doi-asserted-by":"crossref","award":["IIRPSG-2024-01-02313"],"award-info":[{"award-number":["IIRPSG-2024-01-02313"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01927-8","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:33:19Z","timestamp":1760419999000},"page":"1101-1128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sanguinarine and Doxorubicin Inhibit Heat Shock Protein HSPA5 and Trigger ER Stress in Breast Cancer"],"prefix":"10.1007","volume":"84","author":[{"given":"Priyamvada","family":"Bhamidipati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama Rao","family":"Malla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"3","key":"1927_CR1","doi-asserted-by":"publisher","first-page":"a013169","DOI":"10.1101\/cshperspect.a013169","volume":"5","author":"BM Gardner","year":"2013","unstructured":"Gardner, B. M., Pincus, D., & Gotthardt, K. (2013). Gallagher &P. Walter, Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harbor Perspectives in Biology, 5(3), a013169.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"1927_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.gene.2017.03.005","volume":"618","author":"J Wang","year":"2017","unstructured":"Wang, J., & Lee, J. (2017). Liem &P. Ping, HSPA5 gene encoding Hsp70 chaperone bip in the Endoplasmic reticulum. Gene, 618, 14\u201323.","journal-title":"Gene"},{"issue":"4","key":"1927_CR3","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/ijms20040857","volume":"20","author":"L. Sisinni","year":"2019","unstructured":"Sisinni, L. (2019). Endoplasmic reticulum stress and unfolded protein response in breast cancer: The balance between apoptosis and autophagy and its role in drug resistance. International Journal of Molecular Sciences, 20(4), 857-874.","journal-title":"International Journal of Molecular Sciences"},{"issue":"23","key":"1927_CR4","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1038\/s41388-021-01821-6","volume":"40","author":"TW Lager","year":"2021","unstructured":"Lager, T. W., Conner, C., Keating, C. R., Warshaw, J. N., & Panopoulos, A. D. (2021). Cell surface GRP78 and Dermcidin cooperate to regulate breast cancer cell migration through Wnt signaling. Oncogene, 40(23), 4050\u20134059.","journal-title":"Oncogene"},{"issue":"4","key":"1927_CR5","doi-asserted-by":"publisher","first-page":"e201900377","DOI":"10.26508\/lsa.201900377","volume":"2","author":"C.C. Tseng","year":"2019","unstructured":"Tseng, C. C. (2019). GRP78 regulates CD44v membrane homeostasis and cell spreading in tamoxifen-resistant breast cancer. Life Sci Alliance, 2(4), e201900377.","journal-title":"Life Sci Alliance"},{"issue":"8","key":"1927_CR6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neo.2019.05.008","volume":"21","author":"CC Tseng","year":"2019","unstructured":"Tseng, C. C., Zhang, P., & Lee, A. S. (2019). The COOH-Terminal Proline-Rich region of GRP78 is a key regulator of its cell surface expression and viability of Tamoxifen-Resistant breast cancer cells. Neoplasia (New York, N.Y.), 21(8), 837\u2013848.","journal-title":"Neoplasia (New York, N.Y.)"},{"issue":"2","key":"1927_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/cas.13458","volume":"109","author":"C Moriya","year":"2018","unstructured":"Moriya, C., et al. (2018). PRDM14 directly interacts with heat shock proteins HSP90\u03b1 and glucose-regulated protein 78. Cancer Science, 109(2), 373\u2013383.","journal-title":"Cancer Science"},{"issue":"11","key":"1927_CR8","doi-asserted-by":"publisher","first-page":"e80071","DOI":"10.1371\/journal.pone.0080071","volume":"8","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y., et al. (2013). Cancer cells resistant to therapy promote cell surface relocalization of GRP78 which complexes with PI3K and enhances PI(3,4,5)P3 production. PLoS One, 8(11), e80071.","journal-title":"PLoS One"},{"key":"1927_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biocel.2016.05.021","volume":"77(Pt A)","author":"R Pujari","year":"2016","unstructured":"Pujari, R., et al. (2016). Tamoxifen-induced cytotoxicity in breast cancer cells is mediated by glucose-regulated protein 78 (GRP78) via AKT (Thr308) regulation. International Journal of Biochemistry & Cell Biology, 77(Pt A), 57\u201367.","journal-title":"International Journal of Biochemistry & Cell Biology"},{"issue":"3","key":"1927_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1245\/s10434-014-4061-3","volume":"22","author":"HA Chen","year":"2015","unstructured":"Chen, H. A., et al. (2015). E1A-mediated Inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer. Annals of Surgical Oncology, 22(3), 889\u2013898.","journal-title":"Annals of Surgical Oncology"},{"issue":"1","key":"1927_CR11","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1038\/s41598-020-60269-y","volume":"10","author":"C Conner","year":"2020","unstructured":"Conner, C., et al. (2020). Cell surface GRP78 promotes stemness in normal and neoplastic cells. Scientific Reports, 10(1), 3474.","journal-title":"Scientific Reports"},{"issue":"2","key":"1927_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.canlet.2012.07.004","volume":"325","author":"C Li","year":"2012","unstructured":"Li, C., Harada, A., & Oh, Y. (2012). IGFBP-3 sensitizes antiestrogen-resistant breast cancer cells through interaction with GRP78. Cancer Letters, 325(2), 200\u2013206.","journal-title":"Cancer Letters"},{"issue":"12","key":"1927_CR13","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1016\/j.bbamcr.2013.09.013","volume":"1833","author":"DH Kong","year":"2013","unstructured":"Kong, D. H., et al. (2013). BAG3 sensitizes cancer cells exposed to DNA damaging agents via direct interaction with GRP78. Biochimica Et Biophysica Acta, 1833(12), 3245\u20133253.","journal-title":"Biochimica Et Biophysica Acta"},{"key":"1927_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0065-2660(10)69006-2","volume":"69","author":"M Sato","year":"2010","unstructured":"Sato, M., & Yao, V. J. (2010). Arap &R. Pasqualini, GRP78 signaling hub a receptor for targeted tumor therapy. Advances in Genetics, 69, 97\u2013114.","journal-title":"Advances in Genetics"},{"issue":"1","key":"1927_CR15","doi-asserted-by":"publisher","first-page":"2092328","DOI":"10.1080\/2162402X.2022.2092328","volume":"11","author":"O Kepp","year":"2022","unstructured":"Kepp, O., Bezu, L., & Kroemer, G. (2022). The Endoplasmic reticulum chaperone bip: A target for Immunogenic cell death inducers? Oncoimmunology, 11(1), 2092328.","journal-title":"Oncoimmunology"},{"issue":"23","key":"1927_CR16","doi-asserted-by":"publisher","first-page":"10407","DOI":"10.1021\/jacs.2c02435","volume":"144","author":"X Xiong","year":"2022","unstructured":"Xiong, X., et al. (2022). Target profiling of an Iridium(III)-Based Immunogenic cell death inducer unveils the engagement of unfolded protein response regulator bip. Journal of the American Chemical Society, 144(23), 10407\u201310416.","journal-title":"Journal of the American Chemical Society"},{"issue":"7","key":"1927_CR17","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/tox.23793","volume":"38","author":"PJ Wu","year":"2023","unstructured":"Wu, P. J., et al. (2023). Induction of Immunogenic cell death effect of licoricidin in cervical cancer cells by enhancing Endoplasmic reticulum stress-mediated high mobility group box 1 expression. Environmental Toxicology, 38(7), 1641\u20131650.","journal-title":"Environmental Toxicology"},{"key":"1927_CR18","doi-asserted-by":"publisher","first-page":"870914","DOI":"10.3389\/fonc.2022.870914","volume":"12","author":"M Xu","year":"2022","unstructured":"Xu, M., et al. (2022). Immunogenic cell Death-Relevant Damage-Associated molecular patterns and sensing receptors in Triple-Negative breast cancer molecular subtypes and implications for immunotherapy. Frontiers in Oncology, 12, 870914.","journal-title":"Frontiers in Oncology"},{"issue":"4","key":"1927_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cytogfr.2013.05.001","volume":"24","author":"O Kepp","year":"2013","unstructured":"Kepp, O., et al. (2013). Crosstalk between ER stress and Immunogenic cell death. Cytokine & Growth Factor Reviews, 24(4), 311\u2013318.","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"9","key":"1927_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.trecan.2017.07.002","volume":"3","author":"N Rufo","year":"2017","unstructured":"Rufo, N., Garg, A. D., & Agostinis, P. (2017). The unfolded protein response in Immunogenic cell death and cancer immunotherapy. Trends in Cancer, 3(9), 643\u2013658.","journal-title":"Trends in Cancer"},{"issue":"1","key":"1927_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s10238-024-01482-1","volume":"24","author":"Y Wang","year":"2024","unstructured":"Wang, Y., et al. (2024). Comprehensive review of drug-mediated ICD Inhibition of breast cancer: mechanism, status, and prospects. Clin Exp Med, 24(1), 230.","journal-title":"Clin Exp Med"},{"key":"1927_CR22","doi-asserted-by":"publisher","first-page":"115565","DOI":"10.1016\/j.bcp.2023.115565","volume":"212","author":"RR Malla","year":"2023","unstructured":"Malla, R. R., Bhamidipati, P., & Adem, M. (2023). Insights into the potential of sanguinarine as a promising therapeutic option for breast cancer. Biochemical Pharmacology, 212, 115565.","journal-title":"Biochemical Pharmacology"},{"key":"1927_CR23","doi-asserted-by":"publisher","first-page":"116406","DOI":"10.1016\/j.biopha.2024.116406","volume":"173","author":"LJ Huang","year":"2024","unstructured":"Huang, L. J., et al. (2024). Bioactivity and mechanism of action of sanguinarine and its derivatives in the past 10 years. Biomedicine & Pharmacotherapy, 173, 116406.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"1927_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41523-025-00750-x","volume":"11","author":"SK Karthikeyan","year":"2025","unstructured":"Karthikeyan, S. K., et al. (2025). MammOnc-DB, an integrative breast cancer data analysis platform for target discovery. NPJ Breast Cancer, 11(1), 35.","journal-title":"NPJ Breast Cancer"},{"issue":"5","key":"1927_CR25","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.3390\/ijms22052622","volume":"22","author":"\u00c1. Bartha","year":"2021","unstructured":"Bartha, \u00c1., & Gy\u0151rffy, B. (2021). TNMplot.com: A web tool for the comparison of gene expression in Normal, tumor and metastatic tissues. International Journal of Molecular Sciences, 22(5), 2622-2634.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"1927_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41598-017-00535-8","volume":"7","author":"C Lv","year":"2017","unstructured":"Lv, C., et al. (2017). The gene expression profiles in response to 102 traditional Chinese medicine (TCM) components: A general template for research on TCMs. Scientific Reports, 7(1), 352.","journal-title":"Scientific Reports"},{"key":"1927_CR27","unstructured":"Oliveros, J. C. (2007). VENNY. An interactive tool for comparing lists with Venn Diagrams. http:\/\/bioinfogp.cnb.csic.es\/tools\/venny\/index. html."},{"issue":"11","key":"1927_CR28","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang, D., et al. (2023). SRplot: A free online platform for data visualization and graphing. PLoS One, 18(11), e0294236.","journal-title":"PLoS One"},{"issue":"8","key":"1927_CR29","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge, S. X., Jung, D., & Yao, R. (2020). ShinyGO: A graphical gene-set enrichment tool for animals and plants. Bioinformatics, 36(8), 2628\u20132629.","journal-title":"Bioinformatics"},{"issue":"1","key":"1927_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1758-2946-3-12","volume":"3","author":"AP Norgan","year":"2011","unstructured":"Norgan, A. P., Coffman, P. K., & Kocher, J. P. (2011). Katzmann &C.P. Sosa, Multilevel parallelization of AutoDock 4.2. Journal of Cheminformatics, 3(1), 12.","journal-title":"Journal of Cheminformatics"},{"key":"1927_CR31","first-page":"831","volume":"12","author":"SM Rizvi","year":"2013","unstructured":"Rizvi, S. M. (2013). Shakil &M. Haneef, A simple click by click protocol to perform docking: AutoDock 4.2 made easy for non-bioinformaticians. Excli J, 12, 831\u2013857.","journal-title":"Excli J"},{"issue":"12","key":"1927_CR32","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.str.2016.11.012","volume":"24","author":"S Yuan","year":"2016","unstructured":"Yuan, S., Chan, H. S., Filipek, S., & Vogel, H. (2016). PyMOL and inkscape Bridge the data and the data visualization. Structure (London, England : 1993), 24(12), 2041\u20132042.","journal-title":"Structure (London, England : 1993)"},{"key":"1927_CR33","doi-asserted-by":"crossref","unstructured":"Ferrari, I. V., & Patrizio, P. (2021). Development and validation molecular docking analysis of human serum albumin (HSA). BioRxiv, : p. 2021.07. 09.451789.","DOI":"10.1101\/2021.07.09.451789"},{"issue":"1","key":"1927_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.24198\/ijcb.v2i1.46322","volume":"2","author":"U Baroroh","year":"2023","unstructured":"Baroroh, U., et al. (2023). Molecular interaction analysis and visualization of protein-ligand Docking using biovia discovery studio visualizer. Indonesian Journal of Computational Biology (IJCB), 2(1), 22\u201330.","journal-title":"Indonesian Journal of Computational Biology (IJCB)"},{"issue":"2","key":"1927_CR35","first-page":"e1298","volume":"7","author":"S Yuan","year":"2017","unstructured":"Yuan, S., Chan, H. S., & Hu, Z. (2017). Using PyMOL as a platform for computational drug design. Wiley Interdisciplinary Reviews: Computational Molecular Science, 7(2), e1298.","journal-title":"Wiley Interdisciplinary Reviews: Computational Molecular Science"},{"issue":"12","key":"1927_CR36","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1021\/acs.jcim.3c00175","volume":"63","author":"A Wacha","year":"2023","unstructured":"Wacha, A. (2023). Varga &T. Beke-Somfai, Comparative study of molecular mechanics force fields for \u03b2-Peptidic foldamers: Folding and Self-Association. Journal of Chemical Information and Modeling, 63(12), 3799\u20133813.","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"12","key":"1927_CR37","doi-asserted-by":"publisher","first-page":"167598","DOI":"10.1016\/j.jmb.2022.167598","volume":"434","author":"S Katsube","year":"2022","unstructured":"Katsube, S., Liang, R., Amin, A., Hariharan, P., & Guan, L. (2022). Molecular basis for the cation selectivity of Salmonella typhimurium melibiose permease. Journal of Molecular Biology, 434(12), 167598.","journal-title":"Journal of Molecular Biology"},{"issue":"5","key":"1927_CR38","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1021\/acs.jctc.2c01032","volume":"19","author":"B F\u00e1bi\u00e1n","year":"2023","unstructured":"F\u00e1bi\u00e1n, B. (2023). Thallmair &G. Hummer, Optimal bond constraint topology for molecular dynamics simulations of cholesterol. Journal of Chemical Theory and Computation, 19(5), 1592\u20131601.","journal-title":"Journal of Chemical Theory and Computation"},{"key":"1927_CR39","doi-asserted-by":"publisher","first-page":"118901","DOI":"10.1016\/j.molliq.2022.118901","volume":"354","author":"S Ghahremanian","year":"2022","unstructured":"Ghahremanian, S., Rashidi, M. M., Raeisi, K., & Toghraie, D. (2022). Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review. Journal of Molecular Liquids, 354, 118901.","journal-title":"Journal of Molecular Liquids"},{"key":"1927_CR40","doi-asserted-by":"publisher","first-page":"122681","DOI":"10.1016\/j.lfs.2024.122681","volume":"348","author":"J Park","year":"2024","unstructured":"Park, J., et al. (2024). GRP78 Blockade overcomes acquired resistance to EGFR-tyrosine kinase inhibitors in non-small cell lung cancer. Life Sciences, 348, 122681.","journal-title":"Life Sciences"},{"issue":"8","key":"1927_CR41","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/2211-5463.12645","volume":"9","author":"S Bandla","year":"2019","unstructured":"Bandla, S., Diaz, S., Nasheuer, H. P., & FitzGerald, U. (2019). ATPase activity of human binding Immunoglobulin protein (BiP) variants is enhanced by signal sequence and physiological concentrations of Mn(2). FEBS Open Bio, 9(8), 1355\u20131369.","journal-title":"FEBS Open Bio"},{"issue":"2","key":"1927_CR42","doi-asserted-by":"publisher","first-page":"e14600","DOI":"10.1111\/cbdd.14600","volume":"104","author":"DB Kundrapu","year":"2024","unstructured":"Kundrapu, D. B., Chaitanya, A. K., Manaswi, K., Kumari, S., & Malla, R. (2024). Quercetin and taxifolin inhibits TMPRSS2 activity and its interaction with EGFR in paclitaxel-resistant breast cancer cells: An in Silico and in vitro study. Chemical Biology & Drug Design, 104(2), e14600.","journal-title":"Chemical Biology & Drug Design"},{"key":"1927_CR43","doi-asserted-by":"publisher","first-page":"107681","DOI":"10.1016\/j.jmgm.2020.107681","volume":"100","author":"M Akella","year":"2020","unstructured":"Akella, M., & Malla, R. (2020). Molecular modeling and in vitro study on Pyrocatechol as potential pharmacophore of CD151 inhibitor. Journal of Molecular Graphics and Modelling, 100, 107681.","journal-title":"Journal of Molecular Graphics and Modelling"},{"issue":"6","key":"1927_CR44","doi-asserted-by":"publisher","first-page":"e0158256","DOI":"10.1371\/journal.pone.0158256","volume":"11","author":"SJ Hughes","year":"2016","unstructured":"Hughes, S. J., et al. (2016). Correction: Probing the ATP site of GRP78 with nucleotide triphosphate analogs. PLoS One, 11(6), e0158256.","journal-title":"PLoS One"},{"key":"1927_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.mcb.2018.09.014","volume":"149","author":"S Pandey","year":"2019","unstructured":"Pandey, S., Roy, D., & Shukla, A. K. (2019). Measuring surface expression and endocytosis of GPCRs using whole-cell ELISA. Methods in Cell Biology, 149, 131\u2013140.","journal-title":"Methods in Cell Biology"},{"issue":"3","key":"1927_CR46","first-page":"326","volume":"12","author":"GA Bishop","year":"1992","unstructured":"Bishop, G. A., & Hwang, J. (1992). Use of a cellular ELISA for the detection of cell surface antigens. Biotechniques, 12(3), 326\u2013330.","journal-title":"Biotechniques"},{"issue":"12","key":"1927_CR47","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.4155\/fmc.15.80","volume":"7","author":"KL Cook","year":"2015","unstructured":"Cook, K. L., & Clarke, R. (2015). Role of GRP78 in promoting therapeutic-resistant breast cancer. Future Med Chem, 7(12), 1529\u20131534.","journal-title":"Future Med Chem"},{"issue":"1","key":"1927_CR48","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.18632\/aging.202258","volume":"13","author":"X Tang","year":"2020","unstructured":"Tang, X., et al. (2020). Therapeutic potential of targeting HSPA5 through dual regulation of two candidate prognostic biomarkers ANXA1 and PSAT1 in osteosarcoma. Aging (Albany NY), 13(1), 1212\u20131235.","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"1927_CR49","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00280-022-04400-y","volume":"89","author":"RE Nicoletto","year":"2022","unstructured":"Nicoletto, R. E., & Ofner3, C. M. (2022). Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells. Cancer Chemotherapy and Pharmacology, 89(3), 285\u2013311.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"2","key":"1927_CR50","first-page":"pCd012873","volume":"2","author":"M Zaheed","year":"2019","unstructured":"Zaheed, M., Wilcken, N., Willson, M. L., O\u2019Connell, D. L., & Goodwin, A. (2019). Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer. Cochrane Database Systematic Review, 2(2), pCd012873.","journal-title":"Cochrane Database Systematic Review"},{"issue":"5","key":"1927_CR51","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12094-007-0059-7","volume":"9","author":"LG Est\u00e9vez","year":"2007","unstructured":"Est\u00e9vez, L. G., et al. (2007). Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: Results of a phase II study. Clinical and Translational Oncology, 9(5), 317\u2013322.","journal-title":"Clinical and Translational Oncology"},{"issue":"16","key":"1927_CR52","doi-asserted-by":"publisher","first-page":"7849","DOI":"10.1158\/0008-5472.CAN-06-1660","volume":"66","author":"E Lee","year":"2006","unstructured":"Lee, E., et al. (2006). GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. Cancer Research, 66(16), 7849\u20137853.","journal-title":"Cancer Research"},{"issue":"3","key":"1927_CR53","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/01443615.2019.1652886","volume":"40","author":"E L\u00f3pez-Mu\u00f1oz","year":"2020","unstructured":"L\u00f3pez-Mu\u00f1oz, E., & Corres-Molina, M. (2020). N. Garc\u00eda-Hern\u00e1ndez, Correlation of the protein expression of GRP78 and BIK\/NBK with prognostic markers in patients with breast cancer and neoadjuvant chemotherapy. Journal of Obstetrics and Gynaecology, 40(3), 419\u2013426.","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"1927_CR54","doi-asserted-by":"publisher","first-page":"BSR20210245","DOI":"10.1042\/BSR20210245","volume":"42","author":"M. Liu","year":"2022","unstructured":"Liu, M. (2022). Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT\/mTOR pathway. Bioscience Reports, 42(1), BSR20210245.","journal-title":"Bioscience Reports"},{"key":"1927_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.biomaterials.2016.03.050","volume":"94","author":"SH Wang","year":"2016","unstructured":"Wang, S. H., et al. (2016). Structure-based optimization of GRP78-binding peptides that enhances efficacy in cancer imaging and therapy. Biomaterials, 94, 31\u201344.","journal-title":"Biomaterials"},{"issue":"22","key":"1927_CR56","doi-asserted-by":"publisher","first-page":"11452","DOI":"10.18632\/oncotarget.2576","volume":"5","author":"A Raiter","year":"2014","unstructured":"Raiter, A., Yerushalmi, R., & Hardy, B. (2014). Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cells. Oncotarget, 5(22), 11452\u201311463.","journal-title":"Oncotarget"},{"issue":"32","key":"1927_CR57","doi-asserted-by":"publisher","first-page":"13322","DOI":"10.1039\/D3NR00800B","volume":"15","author":"J Shin","year":"2023","unstructured":"Shin, J., et al. (2023). A nanotherapeutic approach to selectively eliminate metastatic breast cancer cells by targeting cell surface GRP78. Nanoscale, 15(32), 13322\u201313334.","journal-title":"Nanoscale"},{"issue":"3","key":"1927_CR58","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ijc.25370","volume":"128","author":"E Lee","year":"2011","unstructured":"Lee, E., Nichols, P., Groshen, S., Spicer, D., & Lee, A. S. (2011). GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy. International Journal of Cancer, 128(3), 726\u2013731.","journal-title":"International Journal of Cancer"},{"issue":"16","key":"1927_CR59","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1016\/j.ejca.2015.07.031","volume":"51","author":"N Yamaguchi","year":"2015","unstructured":"Yamaguchi, N., et al. (2015). Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: A bayesian network meta-analysis. European Journal of Cancer, 51(16), 2314\u20132320.","journal-title":"European Journal of Cancer"},{"issue":"1","key":"1927_CR60","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1186\/s12885-022-10189-z","volume":"22","author":"M Sedeman","year":"2022","unstructured":"Sedeman, M., Christowitz, C., de Jager, L., & Engelbrecht, A. M. (2022). Obese mammary tumour-bearing mice are highly sensitive to doxorubicin-induced hepatotoxicity. Bmc Cancer, 22(1), 1240.","journal-title":"Bmc Cancer"},{"issue":"1","key":"1927_CR61","first-page":"87","volume":"36","author":"TA Smith","year":"2016","unstructured":"Smith, T. A., Phyu, S. M., & Akabuogu, E. U. (2016). Effects of administered cardioprotective drugs on treatment response of breast cancer cells. Anticancer Research, 36(1), 87\u201393.","journal-title":"Anticancer Research"},{"key":"1927_CR62","doi-asserted-by":"publisher","first-page":"153503","DOI":"10.1016\/j.phymed.2021.153503","volume":"84","author":"Q Su","year":"2021","unstructured":"Su, Q., et al. (2021). Sanguinarine combats hypoxia-induced activation of EphB4 and HIF-1\u03b1 pathways in breast cancer. Phytomedicine, 84, 153503.","journal-title":"Phytomedicine"},{"issue":"6","key":"1927_CR63","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1111\/jcmm.15056","volume":"24","author":"Q Su","year":"2020","unstructured":"Su, Q., et al. (2020). Sanguinarine disrupts the colocalization and interaction of HIF-1\u03b1 with tyrosine and Serine phosphorylated-STAT3 in breast cancer. Journal of Cellular and Molecular Medicine, 24(6), 3756\u20133761.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"2","key":"1927_CR64","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3892\/or.2015.4054","volume":"34","author":"S Gu","year":"2015","unstructured":"Gu, S., et al. (2015). Sanguinarine-induced apoptosis in lung adenocarcinoma cells is dependent on reactive oxygen species production and Endoplasmic reticulum stress. Oncology Reports, 34(2), 913\u2013919.","journal-title":"Oncology Reports"},{"issue":"1\u20133","key":"1927_CR65","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejphar.2013.02.035","volume":"705","author":"A Burgeiro","year":"2013","unstructured":"Burgeiro, A., Bento, A. C., Gajate, C., Oliveira, P. J., & Mollinedo, F. (2013). Rapid human melanoma cell death induced by sanguinarine through oxidative stress. European Journal of Pharmacology, 705(1\u20133), 109\u2013118.","journal-title":"European Journal of Pharmacology"},{"issue":"4","key":"1927_CR66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000149719","volume":"54","author":"WY Choi","year":"2008","unstructured":"Choi, W. Y., Kim, G. Y., Lee, W. H., & Choi, Y. H. (2008). Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway. Chemotherapy, 54(4), 279\u2013287.","journal-title":"Chemotherapy"},{"issue":"3","key":"1927_CR67","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/jcb.21672","volume":"104","author":"S Kim","year":"2008","unstructured":"Kim, S., et al. (2008). Sanguinarine-induced apoptosis: Generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL. Journal of Cellular Biochemistry, 104(3), 895\u2013907.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"24","key":"1927_CR68","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.2174\/1381612824666180829100601","volume":"24","author":"C Fu","year":"2018","unstructured":"Fu, C., Guan, G., & Wang, H. (2018). The anticancer effect of sanguinarine: A review. Curr Pharm Des, 24(24), 2760\u20132764.","journal-title":"Curr Pharm Des"},{"issue":"16","key":"1927_CR69","doi-asserted-by":"publisher","first-page":"22355","DOI":"10.18632\/oncotarget.7971","volume":"7","author":"Y Wang","year":"2016","unstructured":"Wang, Y., et al. (2016). Noninvasive bioluminescence imaging of the dynamics of sanguinarine induced apoptosis via activation of reactive oxygen species. Oncotarget, 7(16), 22355\u201322367.","journal-title":"Oncotarget"},{"key":"1927_CR70","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s12272-021-01356-0","volume":"44","author":"J Wang","year":"2021","unstructured":"Wang, J., et al. (2021). Sanguinarine impairs lysosomal function and induces ROS-dependent mitophagy and apoptosis in human hepatocellular carcinoma cells. Archives of Pharmacal Research, 44, 1025\u20131036.","journal-title":"Archives of Pharmacal Research"},{"issue":"3","key":"1927_CR71","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/jcb.21672","volume":"104","author":"S Kim","year":"2008","unstructured":"Kim, S., et al. (2008). Sanguinarine-induced apoptosis: Generation of ROS, down\u2010regulation of Bcl\u20102, c\u2010FLIP, and synergy with TRAIL. Journal of Cellular Biochemistry, 104(3), 895\u2013907.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"1","key":"1927_CR72","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1038\/s41467-022-33291-z","volume":"13","author":"S Chawla","year":"2022","unstructured":"Chawla, S., et al. (2022). Gene expression based inference of cancer drug sensitivity. Nature Communications, 13(1), 5680.","journal-title":"Nature Communications"},{"issue":"4","key":"1927_CR73","doi-asserted-by":"publisher","first-page":"323","DOI":"10.21873\/cgp.20385","volume":"20","author":"SS Messeha","year":"2023","unstructured":"Messeha, S. S., et al. (2023). Involvement of AKT\/PI3K pathway in sanguinarine\u2019s induced apoptosis and cell cycle arrest in Triple-negative breast cancer cells. Cancer Genomics & Proteomics, 20(4), 323\u2013342.","journal-title":"Cancer Genomics & Proteomics"},{"issue":"1","key":"1927_CR74","doi-asserted-by":"publisher","first-page":"90","DOI":"10.20892\/j.issn.2095-3941.2016.0086","volume":"14","author":"YL Zhang","year":"2017","unstructured":"Zhang, Y. L., Wang, R. C., & Cheng, K. (2017). Ring &L. Su, Roles of Rap1 signaling in tumor cell migration and invasion. Cancer Biol Med, 14(1), 90\u201399.","journal-title":"Cancer Biol Med"},{"issue":"1","key":"1927_CR75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2047-783X-18-5","volume":"18","author":"G Yu","year":"2013","unstructured":"Yu, G., Wang, L., Li, Y., Ma, Z., & Li, Y. (2013). Identification of drug candidate for osteoporosis by computational bioinformatics analysis of gene expression profile. European Journal of Medical Research, 18(1), 5.","journal-title":"European Journal of Medical Research"},{"issue":"10","key":"1927_CR76","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/j.1742-4658.2006.05227.x","volume":"273","author":"M Lopus","year":"2006","unstructured":"Lopus, M., & Panda, D. (2006). The benzophenanthridine alkaloid sanguinarine perturbs microtubule assembly dynamics through tubulin binding. A possible mechanism for its antiproliferative activity. Febs J, 273(10), 2139\u20132150.","journal-title":"Febs J"},{"issue":"15","key":"1927_CR77","doi-asserted-by":"publisher","first-page":"8329","DOI":"10.3390\/ijms23158329","volume":"23","author":"S.S. Messeha","year":"2022","unstructured":"Messeha, S. S., Zarmouh, N. O., Antonie, L., & Soliman, K. F. A. (2022). Sanguinarine Inhibition of TNF-\u03b1-Induced CCL2, IKBKE\/NF-\u03baB\/ERK1\/2 signaling Pathway, and cell migration in human Triple-Negative breast cancer cells. International Journal of Molecular Sciences, 23(15), 8329.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2\u20133","key":"1927_CR78","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cbi.2008.11.009","volume":"179","author":"YH Choi","year":"2009","unstructured":"Choi, Y. H., et al. (2009). Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells. Chem Biol Interact, 179(2\u20133), 185\u2013191.","journal-title":"Chem Biol Interact"},{"key":"1927_CR79","doi-asserted-by":"publisher","first-page":"153500","DOI":"10.1016\/j.phymed.2021.153500","volume":"84","author":"MA Ghauri","year":"2021","unstructured":"Ghauri, M. A., et al. (2021). Sanguinarine impedes metastasis and causes inversion of epithelial to mesenchymal transition in breast cancer. Phytomedicine, 84, 153500.","journal-title":"Phytomedicine"},{"key":"1927_CR80","doi-asserted-by":"publisher","first-page":"12457","DOI":"10.2147\/CMAR.S280009","volume":"12","author":"L Lyu","year":"2020","unstructured":"Lyu, L., et al. (2020). Overexpression of FAM234B predicts poor prognosis in patients with luminal breast cancer. Cancer Manag Res, 12, 12457\u201312471.","journal-title":"Cancer Manag Res"},{"issue":"14","key":"1927_CR81","doi-asserted-by":"publisher","first-page":"e34506","DOI":"10.1016\/j.heliyon.2024.e34506","volume":"10","author":"AM Almatrafi","year":"2024","unstructured":"Almatrafi, A. M., & Alamery &, S. (2024). Expression pattern analysis of the MAGE family genes in breast cancer patients and hypomethylation activation in the MCF-7 cells. Heliyon, 10(14), e34506.","journal-title":"Heliyon"},{"issue":"1","key":"1927_CR82","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.arcmed.2013.10.005","volume":"45","author":"SY Hou","year":"2014","unstructured":"Hou, S. Y., et al. (2014). Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism. Archives of Medical Research, 45(1), 44\u201351.","journal-title":"Archives of Medical Research"},{"issue":"3","key":"1927_CR83","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/1535370217746383","volume":"243","author":"LR Yu","year":"2018","unstructured":"Yu, L. R., et al. (2018). Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients. Exp Biol Med (Maywood), 243(3), 248\u2013255.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"1927_CR84","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41389-022-00379-6","volume":"11","author":"T Wu","year":"2022","unstructured":"Wu, T., et al. (2022). EDDM3A drives gastric cancer progression by promoting HIF-1\u03b1-dependent aerobic Glycolysis. Oncogenesis, 11(1), 3.","journal-title":"Oncogenesis"},{"issue":"10","key":"1927_CR85","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1002\/eji.201242505","volume":"43","author":"L Hannesd\u00f3ttir","year":"2013","unstructured":"Hannesd\u00f3ttir, L., et al. (2013). Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response. European Journal of Immunology, 43(10), 2718\u20132729.","journal-title":"European Journal of Immunology"},{"issue":"2","key":"1927_CR86","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3892\/or.2015.4047","volume":"34","author":"YS Kwon","year":"2015","unstructured":"Kwon, Y. S., Chun, S. Y., Nam, K. S., & Kim, S. (2015). Lapatinib sensitizes quiescent MDA-MB-231 breast cancer cells to doxorubicin by inhibiting the expression of multidrug resistance-associated protein-1. Oncology Reports, 34(2), 884\u2013890.","journal-title":"Oncology Reports"},{"issue":"3","key":"1927_CR87","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/annonc\/mdx773","volume":"29","author":"SM Swain","year":"2018","unstructured":"Swain, S. M., et al. (2018). Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): A phase II, open-label, multicenter, multinational cardiac safety study. Annals of Oncology, 29(3), 646\u2013653.","journal-title":"Annals of Oncology"},{"issue":"9","key":"1927_CR88","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12032-024-02468-5","volume":"41","author":"MC Karthikeyan","year":"2024","unstructured":"Karthikeyan, M. C., et al. (2024). Doxorubicin downregulates cell cycle regulatory hub genes in breast cancer cells. Medical Oncology, 41(9), 220.","journal-title":"Medical Oncology"},{"issue":"12","key":"1927_CR89","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1745-7270.2007.00361.x","volume":"39","author":"L Sun","year":"2007","unstructured":"Sun, L., et al. (2007). Knockdown of S-phase kinase-associated protein-2 expression in MCF-7 inhibits cell growth and enhances the cytotoxic effects of epirubicin. Acta Biochimica Et Biophysica Sinica (Shanghai), 39(12), 999\u20131007.","journal-title":"Acta Biochimica Et Biophysica Sinica (Shanghai)"},{"issue":"1","key":"1927_CR90","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12943-024-02067-y","volume":"23","author":"HX Shi","year":"2024","unstructured":"Shi, H. X., et al. (2024). Targeting DKK1 enhances the antitumor activity of Paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer. Molecular Cancer, 23(1), 152.","journal-title":"Molecular Cancer"},{"issue":"6","key":"1927_CR91","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3325\/cmj.2014.55.638","volume":"55","author":"Z Wang","year":"2014","unstructured":"Wang, Z., et al. (2014). Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk. Croat Med J, 55(6), 638\u2013646.","journal-title":"Croat Med J"},{"issue":"8","key":"1927_CR92","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.7150\/thno.72192","volume":"12","author":"T Kim","year":"2022","unstructured":"Kim, T., et al. (2022). TRIB1 regulates tumor growth via controlling tumor-associated macrophage phenotypes and is associated with breast cancer survival and treatment response. Theranostics, 12(8), 3584\u20133600.","journal-title":"Theranostics"},{"issue":"25","key":"1927_CR93","doi-asserted-by":"publisher","first-page":"12452","DOI":"10.1073\/pnas.1818521116","volume":"116","author":"M Morotti","year":"2019","unstructured":"Morotti, M., et al. (2019). Hypoxia-induced switch in SNAT2\/SLC38A2 regulation generates endocrine resistance in breast cancer. Proc Natl Acad Sci U S A, 116(25), 12452\u201312461.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"37","key":"1927_CR94","doi-asserted-by":"publisher","first-page":"39714","DOI":"10.18632\/oncotarget.5356","volume":"6","author":"MH Aziz","year":"2015","unstructured":"Aziz, M. H., et al. (2015). Suppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo. Oncotarget, 6(37), 39714\u201339724.","journal-title":"Oncotarget"},{"issue":"1","key":"1927_CR95","doi-asserted-by":"publisher","first-page":"21159","DOI":"10.1038\/s41598-021-00291-w","volume":"11","author":"R Binato","year":"2021","unstructured":"Binato, R., et al. (2021). NRIP1 is activated by C-JUN\/C-FOS and activates the expression of PGR, ESR1 and CCND1 in luminal A breast cancer. Scientific Reports, 11(1), 21159.","journal-title":"Scientific Reports"},{"key":"1927_CR96","first-page":"1","volume":"69","author":"M. El-Readi","year":"2024","unstructured":"El-Readi, M. Z. (2024). Doxorubicin-sanguinarine nanoparticles: Formulation and evaluation of breast cancer cell apoptosis and cell cycle. Drug Development and Industrial Pharmacy, 69, 1-33","journal-title":"Drug Development and Industrial Pharmacy"},{"issue":"14","key":"1927_CR97","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.phymed.2012.08.010","volume":"19","author":"SY Eid","year":"2012","unstructured":"Eid, S. Y., El-Readi, M. Z., & Wink, M. (2012). Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells. Phytomedicine, 19(14), 1288\u20131297.","journal-title":"Phytomedicine"},{"issue":"1","key":"1927_CR98","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40360-018-0284-4","volume":"20","author":"X Wang","year":"2019","unstructured":"Wang, X., Decker, C. C., & Zechner, L. (2019). Krstin &M. Wink, In vitro wound healing of tumor cells: Inhibition of cell migration by selected cytotoxic alkaloids. BMC Pharmacol Toxicol, 20(1), 4.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"12","key":"1927_CR99","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.bcp.2008.09.003","volume":"76","author":"SI Bae","year":"2008","unstructured":"Bae, S. I., Zhao, R., & Snapka, R. M. (2008). PCNA damage caused by antineoplastic drugs. Biochemical Pharmacology, 76(12), 1653\u20131668.","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"1927_CR100","first-page":"40","volume":"14","author":"OS Troitskaya","year":"2022","unstructured":"Troitskaya, O. S., Novak, D. D., Richter, V. A., & Koval, O. A. (2022). Immunogenic Cell Death in Cancer Therapy Acta Naturae, 14(1): 40\u201353.","journal-title":"Immunogenic Cell Death in Cancer Therapy Acta Naturae"},{"issue":"15","key":"1927_CR101","doi-asserted-by":"publisher","first-page":"8375","DOI":"10.3390\/ijms25158375","volume":"25","author":"A. Duda-Madej","year":"2024","unstructured":"Duda-Madej, A., Viscardi, S., Szewczyk, W., & Topola, E. (2024). Natural alkaloids in cancer therapy: Berberine, sanguinarine and chelerythrine against colorectal and gastric cancer. International Journal of Molecular Sciences, 25(15), 8375.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"1927_CR102","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1038\/s41598-018-22905-6","volume":"8","author":"K Gurusinghe","year":"2018","unstructured":"Gurusinghe, K., Mishra, A., & Mishra, S. (2018). Glucose-regulated protein 78 substrate-binding domain alters its conformation upon EGCG inhibitor binding to nucleotide-binding domain: Molecular dynamics studies. Scientific Reports, 8(1), 5487.","journal-title":"Scientific Reports"},{"issue":"18","key":"1927_CR103","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.3390\/molecules24183293","volume":"24","author":"J.A. Bauer","year":"2019","unstructured":"Bauer, J. A., Pavlovi\u0107, J. & Bauerov\u00e1-Hlinkov\u00e1, V. (2019). Normal mode analysis as a routine part of a structural investigation. Molecules, 24(18), 3293.","journal-title":"Molecules"},{"issue":"1","key":"1927_CR104","doi-asserted-by":"publisher","first-page":"8175","DOI":"10.1038\/s41467-024-52478-0","volume":"15","author":"MA Graewert","year":"2024","unstructured":"Graewert, M. A., et al. (2024). Structural basis of CDNF interaction with the UPR regulator GRP78. Nature Communications, 15(1), 8175.","journal-title":"Nature Communications"},{"key":"1927_CR105","doi-asserted-by":"publisher","first-page":"101020","DOI":"10.1016\/j.neo.2024.101020","volume":"55","author":"V Yamamoto","year":"2024","unstructured":"Yamamoto, V., et al. (2024). GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors. Neoplasia (New York, N.Y.), 55, 101020.","journal-title":"Neoplasia (New York, N.Y.)"},{"issue":"5","key":"1927_CR106","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bcp.2012.09.012","volume":"85","author":"AH Sch\u00f6nthal","year":"2013","unstructured":"Sch\u00f6nthal, A. H. (2013). Pharmacological targeting of Endoplasmic reticulum stress signaling in cancer. Biochemical Pharmacology, 85(5), 653\u2013666.","journal-title":"Biochemical Pharmacology"},{"issue":"9","key":"1927_CR107","doi-asserted-by":"publisher","first-page":"e19806","DOI":"10.1016\/j.heliyon.2023.e19806","volume":"9","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Tao, Y., Hu, K., & Lu, J. (2023). GRP78 inhibitor HA15 increases the effect of bortezomib on eradicating multiple myeloma cells through triggering Endoplasmic reticulum stress. Heliyon, 9(9), e19806.","journal-title":"Heliyon"},{"issue":"5","key":"1927_CR108","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.ajpath.2011.07.031","volume":"179","author":"A Mozos","year":"2011","unstructured":"Mozos, A., et al. (2011). The expression of the Endoplasmic reticulum stress sensor BiP\/GRP78 predicts response to chemotherapy and determines the efficacy of proteasome inhibitors in diffuse large b-cell lymphoma. American Journal of Pathology, 179(5), 2601\u20132610.","journal-title":"American Journal of Pathology"},{"issue":"1","key":"1927_CR109","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1021\/acs.molpharmaceut.7b00830","volume":"15","author":"GB Ding","year":"2018","unstructured":"Ding, G. B., et al. (2018). A novel doxorubicin prodrug with GRP78 recognition and Nucleus-Targeting ability for safe and effective cancer therapy. Molecular Pharmaceutics, 15(1), 238\u2013246.","journal-title":"Molecular Pharmaceutics"},{"issue":"2","key":"1927_CR110","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3892\/ijo.2016.3558","volume":"49","author":"N Pilco-Ferreto","year":"2016","unstructured":"Pilco-Ferreto, N., & Calaf, G. M. (2016). Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines. International Journal of Oncology, 49(2), 753\u2013762.","journal-title":"International Journal of Oncology"},{"issue":"5","key":"1927_CR111","first-page":"6243","volume":"14","author":"B Buranrat","year":"2017","unstructured":"Buranrat, B., Suwannaloet, W., & Naowaboot, J. (2017). Simvastatin potentiates doxorubicin activity against MCF-7 breast cancer cells. Oncol Lett, 14(5), 6243\u20136250.","journal-title":"Oncol Lett"},{"key":"1927_CR112","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fphar.2016.00249","volume":"7","author":"L Wang","year":"2016","unstructured":"Wang, L., et al. (2016). A novel agent enhances the chemotherapeutic efficacy of doxorubicin in MCF-7 breast cancer cells. Frontiers in Pharmacology, 7, 249.","journal-title":"Frontiers in Pharmacology"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01927-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01927-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01927-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T06:01:38Z","timestamp":1772863298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01927-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1927"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01927-8","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"1 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}